FDA Approved: TOBRAMYCIN — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for tobramycin by Mylan Institutional LLC (ANDA065407). This action approves the generic tobramycin product for the mark…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TOBRAMYCIN (Tobramycin)

Snippet

SUPPL AP for TOBRAMYCIN (TOBRAMYCIN)